Stockreport

Atreca Announces FDA Clearance of Investigational New Drug Application for ATRC-101

Atreca, Inc.  (BCEL) 
Last atreca, inc. earnings: 3/11 04:30 pm Check Earnings Report
PDF First IND clearance of a clinical candidate derived from Atreca’s differentiated drug discovery platform  Phase 1b clinical trial in patients with solid tumors to [Read more]